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Abstract 
This paper summarizes our studies of 
IUD-related disease with those previously 
published by others. Our data are based upon 51 
IUDs and 42 index cases of IUD-related disease 
demonstrating specific processes. Gross, 
dissecting microscope, scanning electron 
microscope and X-ray microanalysis examinations 
were made of selected IUDs and associated 
tissues. Tissue associated with the IUDs 
revealed inflammation in 59.4%, calcific 
material in 6.3% and no abnormality in :l4.4%. 
JUD-associated tissue responses were accompanied 
by changes of the IUD; these changes involved 
deposition of substances upon the IUD surface 
and degradation of the JUD itself. Disintegra-
tion of the IUD, its string or both, has been 
repeatedly observed. The material deposited 
upon the surface of the IUD included proteins 
and calcium salts. The changes which involve 
the IUD and the host appear to be operative in 
the genesis of IUD-related disease. 
Inflammatory changes and infections are the most 
common IUD-related disease processes and are 
also the mechanisms commonly associated with the 
most serious complications of JUD use, reproduc-
tive failure and death. We propose that serious 
IUD-related disease is caused by or is a direct 
consequence of processes which alter the JUD and 
which potentiate inflammation and infection. A 
model amenable to testing is proposed. 
Key words: Intrauterine device, IUD, IUD-related 
disease, microanalysis, morphologic analysis, 
pathogenesis, scanning electron microscopy, 
transmission electron microscopy, ultrastructure. 
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Introduction 
In the US* many people prefer non-permanent 
methods of contraception. The IUD, despite 
related health problems, remains a popular, 
reversible means of birth control in this 
country. In the decade from 1973 to 1982 use of 
0CPs decreased by 45.2% while use of the JUD 
decreased by only 26.0%. The IUD is also the 
mainstay of state supported contraception 
programs in a number of so-called emerging 
nations (29). 
IUD usage may be traced back to ancient 
ti mes and is para 11 e 1 ed by the appea ranee of 
IIJD-related diseases (Table 1) (74). The social 
and economic ramifications of such diseases are 
greater than one might imagine. In 1985, AH 
Robbins Co., producer of the Dalkon shield IUD, 
filed for protection under Chapter 11, citing 
immense legal costs and settlements as the pre-
cipitating cause of financial failure. By 
1986, G.D. Searle and Co., the makers of the 
Cu-7 and Tatum-T IUDs, and 0rtho, manufacturer 
of the Lippes Loop, had announced the withdrawal 
of their devices from the market for similar 
reasons. 
It is impossible to objectively measure the 
human suffering associated with JUD-related 
disease but reasonable estimates of the finan-
cial cost may be computed. Table 2 indicates 
the means by which Gupta (20) computed the 
minimum total direct cost of IUD-related PID at 
almost 75 million dollars per year. When all 
varieties of JUD-related disease are included, as 
wel 1 as indirect costs such as time lost and 
decrements in productivity, the total economic 
cost of IUD-related disease in the US may be much 
higher. 
This review summarizes and compares our 
studies of IUD-related disease with those pre-
viously published. The body of literature 
appears sufficiently comprehensive to permit 
conclusions, derivation of hypotheses regarding 
the origin of IUD-related disease and the 
generation of recommendations for the future. 
The uniquely human nature of IUD usage, the 
absence of an animal model with which to explore 
hypotheses and ethical constraints on human 
*See List of Abbreviations at the end of the paper. 
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TABLE 1 
HISTORY OF IUD USAGE AND COMPLICATIONS 
HISTORY OF INTRAUTERINE CONTRACEPTION 
Sett~~g__ __ E_v_e_nt _ __________ _ 











Smooth pebbles in camels' uteri 
(Asia Minor). 
Hippocratic writings describe 
ebony, glass, gold, ivory, 
pewter, wood and wool IUDs. 
Avicenna writings discuss use of 
IUDs. 
Diamond-studded, platinum IUDs. 
Richter, Pust - silkworm gut IUDs. 
Grafenberg - silkworm gut and 
silver wire IUDs. 
Ota (Japan) ring. 
IUDs banned in Japan by governmental 
edict. 
Plastic IUDs with "memory": 
Margulies spiral, Lippes loop, 
Birnbeg bow, Saf-T-Coil. 
Metal devices: Majzlin spring, 
M device. 
Nylon coils (LfM device). 
Copper-?, Copper-T, Dalkon shield. 
ProgestasertTM 








U.S. Department of Health, Education and Welfare, 1978 (74) 
TABLE 2 
HISTORY OF IUD COMPLICATIONS 
Event 
Hippocratic writings record sepsis, 
death associated with IUD use. 
Pelvic sepsis and death. 
Barth, Tietze: fatal pelvic 
actinomycosis. 
Margulies spiral: rigid tail led to 
male dyspareunia. 
Birnbeg bow: bowel obstruction after 
uterine perforation. 
Majzlin Spring: myometrial embedment. 
LEM: in situ fracture and embedment. 
Dalkon shield: mid-trimester septic 
abortion. 
Medicated devices: moderate inter-
menstrual spotting. 
OBJECTIV_E_ECONOMIC CONSEQUENCES _OF IUD-RELATED DISEASE 
Annual estimated cases of acute PIO in the US 
Annual rate of PIO in women 14-34 years old 
Estimated percent of women using IUDs 
Annual rate of PIO in women using IUDs 
Annual rate of PIO in women not using IUDs 
Per cent PIO cases attributable to IUD usage 
Annual estimated cases of PIO due to IUD usage 
(0.22X850,0DO) 
Estimated hospital admissions of PIO patients 
Estimated per case hospitalization cost 
Cost of IUD-related PIO hospitalization 
( 187 ,OOOXO. 25X$l ,000) 
Estimated PIO cases with outpatient care 
Estimated per-case outpatient cost 
Cost of IUD-related PIO outpatient care 
(187,000X0.75X$200) 
TOTAL MINIMUM DIRECT COST OF IUD RELATED PIO 














25~ 0 % 
75.0 % 
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experimentation necessitate a retrospective ana-
lysis. We shall accomplish this by exploring: 
1. the clinical nature of IUD-related disease; 
2. the relationship between clinical and patho-
logical finrlings; 3. the role of morphological 
and microanalytical techniques in clarifying the 
genesis of IUD-related disease. 
Materials and Methods 
The data presented herein include infor-
mation derived from cases not previously 
reported as wel 1 as a series of IUD-related 
actinomycosis cases previously published (62). 
Our cases are derived from 415 IUDs collected 
from Hermann Hospital /The University Hospital, 
the ambulatory care clinics of The University of 
Texas Medical School at Houston, Texas, public 
family planning clinics of the city of Houston 
and those contributed by private practitioners 
of medicine. This collection was initiated in 
1977 and continues to date. Each of the IUDs 
collected has been examined grossly by one of us 
(WAS) and in approximately 50% of the cases 
materi a 1 s and tissues adherent to the I \JO have 
been submitted for routine, light microscopic 
histopathological analysis. The data presented 
here are based in part upon 51 IUDs collected 
during 1985. Tissue specimens from 31 of these 
cases (60.8%) were examined in detail by LM for 
this study. The study al so includes data 
derived from 42 inrlex cases carefully selected 
from the collection. The index cases consist of 
the following: 9 cases of IUD-associated acti-
nomycosis, l case with characteristic cytopatho-
logical findings of IUD-related PID, 1 case of 
'encrusted' IUD characteristic of long-term IUD 
use, one case characteristic of intra-
endometrial calcific material associated with 
IUD use, 28 cases not associated with disease 
where the IUDs were worn for twenty months or 
more, and IUDs from two women with charac-
teristic IUD changes and PIO. 
The nine cases of IUD-associated actino-
mycosis, specimens from which were studied by 
LM, SEM and histochemical methods, have been 
reported previously (62). Routine histological 
examinations of paraffin-embedded tissues from 
the 1985 cases included H&E, PAS with and 
without diastase digestion, Brown-Rrenn, 
Ziehl-Neilsen, and GMS stains. Special prepara-
tions of tissues, IUDs or IUD-strings from the 
index cases included von Kassa, ARS and 
Bunting's MoB stained sections, a Papanicolaou 
stained CV smear, and IUD surface crusts stained 
with ARS. 
Careful gross, dissecting microscope and 
SEM examinations were made of selected IUDs. 
Paraffin-embedded sections of IUD tails and 
IUD-associated 'crusts' stained with H&E, ARS, 
GMS and MoB were examined by routine light and 
polarization microscopy. Portions of the IUDs 
and their tails as well as the ARS stained IUD 
were examined by SEM and XRMA. 
IUDs 1~ere prepared for SEM by gently 
cutting each specimen into pieces approximately 
1 cm in length. Each piece was fixed in 
phosphate buffered, 2% glutaraldehyde; osmium 
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post-fixation was not done to avoid osmium peaks 
during XRMA. Specimen pieces were rinsed in 
buffer, washed thoroughly in distilled water, 
dehydrated with graded ethanols and critical 
point dried from liquid carbon dioxide using a 
Bomar SPC-1500 critical point drier. Specimens 
destined for XRMA were mounted with carbon paint 
on 25 mm carbon stubs. Specimens for detailed 
morphologic analysis were postfixed with an 
osmium/semithiocarbohydrazide technique (45,60) 
and critical point dried as above. 0 Specimens 
for XRMA were coated with 100-150 A carbon using 
an Edwards 306 sputter coater. Specimens for 
detailed 0 morphologic analysis were coated with 
200-300 A gold-palladium under an argon 
atmosphere in an Edwards 306 sputter coater. 
Coated samples were examined in a JEOL SEM 35 
scanning electron microscope equipped with a 
beryl 1 i um window probe for XRMA. The system was 
standardized using a copper grid mounted on an 
aluminum stub. Specimens were examined for non-
cellular material as well as cells and deposits 
on or changes of the IUD surface. The presence 
of non-cellular material, cells or microorga-
nisms was recorded photographically. Following 
SEM examination, XRMA was done at a working 
distance of 39 mm. Spectra were acquired from 
various points on each IUD including sites with 
crusted deposits and apparently uninvolved areas 
of the tail, body and head of the IUD; peaks 
within the spectra were labelled after acquisi-
tion. The spectra obtained from the specimens 
were compared with those derived from identical 
IUDs 1~hich had never been worn and which 
remained in the manufacturers' packages until 
processing. 
Results 
The IUDs received during 1985 included the 
following types: Lippes loop, Oalkon shield, 
Saf-T-Coil, Cu-7, Cu-T and Margulies spiral. 
The numbers of each IUD type and their frequency 
are shown in Table 3; this table also contrasts 
the 1985 cases and the index cases with the 
numbers and frequencies of IUD types collected 
during the period 1977-1986. 
Of the 51 IUDs collected, 9 were received 
without adequate historical documentation while 
42 were accompanied by sufficient clinical 
history to allow correlation between clinical 
and pathological findings. The original gross 
descriptions of the IUDs were insufficient in 24 
cases; upon later examination by one of us 
(WAS), 10 of these 24 cases (41.7%) were found 
to have deposits on the IUD (Fig. 1) or string 
surfaces or there were structural changes of the 
IUD or string. A total of 28 cases had grossly 
recognizable structural changes; each of these 
IUDs had been in place for no less than 2 years. 
The gross structural changes seen included 
deposits of calcareous material (Fig. 2), total 
breaks of the IUD, chips and cracks of IUD sur-
face, absence of, breaks of or deposits upon the 
IUD string, and combinations of the above. 
Thirty-two IUDs (62.7%) came with suf-
ficient amounts of attached tissues to permit 
histopathological examination. In 24 of these 
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TABLE 3 
T_r~~ _AND FREQUENCY OF IUDs COLLECTED AND STUDIED 








Lippes loop+ Cu-7 80.4% 
_NlH __ 
21 C41. 2%) 
20 (39.2%) 




Index cases, N=42; 1977-1986 













Total coll ecti_o_n_,_ -~=3_2_6_;  _1_9_7_7_-_1_9_~~ 
Type 



























*Not identified because of destruction or does-
not fall within recognizable category. 
32 cases (75%), adherent tissues were obtained 
from the surface of the IUD itself. In 8 of 
these cases (25%) tissues were obtained from a 
coincident diagnostic or therapeutic procedure 
(eg., total abdominal hysterectomy, dilatation 
and curettage or endomet rial biopsy, or tubal 
ligation). In 19 cases (37.3%) there was no 
evidence of material attached to the IUD which 
could be used for histopathological examination. 
Histopathological examination of adherent 
or associated tissues revealed chronic inflam-
mation in 28.1% of cases, acute inflammation 
in 31.3% of cases, calcific material in 2 
instances (6.3%), and no evidence of histologic 
abnormality in 11 instances (34.4%). In both 
specimens where calcific material was found in 
adherent endometrial tissues, the IUDs had been 
in pl ace for at least 20 months. In none of the 
cases were organisms found in histologic pre-




Definition of the syndrome: 
Actinomycotic pelvic infection associated with 
IUD use; ranges from organisms in CV smears 
(4.0-25.5%) to pelvic abscesses (0.4-1.4%). 
Characteristics of the syndrome: 




4. IUD types: 
Duration: 





pain, fever, sweats, menstrual 
irregularities. 
pelvic mass, fever (38-40.5 C), 
non-specific. 
3 days - 14 months. 
variable - reflects patterns 
of use. 
6 months - 25 years; 84.7% l_ 
3 years. 
62.5% uni- or bilateral tubo-
ovarian abcess. 
65.6% with subsequent total 
loss of reproductive 
capacity. 
Schmidt et al., 1980 [63) 
was concomitant chronic inflammation in a 
Fallopian tube segment. 
The 9 cases of IUD-associated actinomycotic 
disease have been reported elsewhere (62) (Table 
4). These nine cases demonstrate that female 
reproductive system actinomycotic disease is 
related to IIID use. The occurrence of this 
infectious disease, which is otherwise rarely 
encountered in the female reproductive tract, is 
directly related to the duration the IUD has 
been worn. In our nine cases, and in similar 
cases reported in the literature up to that 
time, 80% of the women afflicted with 
IUD-related actino1nycosis had worn their IUDs 
for more than three years. This infection is 
serious, commonly results in permanent infer-
tility and is not related to life-style, sexual 
habits, race, socioeconomic status or the type 
of IIJD used. 
In three of our nine Actinomyces cases 1~e 
observed characteristic Gupta bodies (20-22,24) 
in CV smears. Gupta bodies, actually complex 
colonies of microorganisms including Actinomyces 
and other pathogens, may be seen in IUD-related 
PIO caused by organisms other than Actinomyces 
( 20). One index case demonstrates the 
appearance of such organisms on CV smears. The 
patient, a woman who had worn her Saf-T-Coil for 
13 years without replacement, was treated for 
severe PIO within one month of finding the cyto-
pathologic changes on her CV smear (Fig. 3). 
Birefringent, crystalline, ARS positive 
staining material is often encountered in 
endo,netrial tissues from women 1~ith long term 
(>2 years) IUD use (33). Both H&E and ARS 
Review of IUD-related Disease 
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Fig. 1: A Lippes loop IUD after removal; arrows 
indicate adherent tissue which may be 
removed for histologic examination. 
Bar = 2cm 
Fig. 2: A Dalkon shield IUD; there is adherent 
tissue and an extensive biodeposit. 
The small white flecks, seen as 
confluent white areas on the distal 
ends of the arms (arrows), are charac-
teristic of surface depositions of 
calcium salts. Bar = 3cm 
stains identify calcium salts in these 
birefringent materials. One of the index cases 
provides a characteristic appearance of these 
crystalline substances in H&E stained sections 
of endornetrial tissue (Fig. 4). These calcific 
materials seem to fonn on the surface of the 
IUD. Figure 5 demonstrates an ARS stained IUD 
which had been in place for more than 2 years. 
This IUD and its string were also examined by 
SEM and subjected to XRMA. The deposits of 
material on the IUD string surface are shown 
clearly in Figure 6. These deposits 
demonstrated spectra of Ca, P, S, and Cl when 
subjected to microanalysis; Figure 7 
demonstrates a typical Ca distribution map for 
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Fig. 3: Light micrograph of a CV smear stained 
with Papanicolaou technique. The 
centrally located fuzzy structure 
(arrow) is a cluster of bacterial orga-
nisms - a Gupta body. Superficial 
(arrow-s) and intermediate (arrow-i) 
epithelial cell nuclei are seen; many 
PMNs are present. Bar= 40µm 
Fig. 4: Light micrograph of a multilammellar, 
calcific body seen in a paraffin section 
of endometrial tissue associated with 
an IUD. The patient was asymptomatic 
and her IUD had Ca concretions on its 
surface. H&E. Bar= 4Qµm 
Surface deposits are observed commonly on 
IUDs which have been in place for at least two 
years and virtually uniformly on those in situ 
for three or more years. The crusts are not, 
however, pathognomonic of IUD-related disease. 
Twenty-eight of our index cases were received 
from an OB/GYN practice composed of high-middle 
to upper socioeconomic class women of uniformly 
conservative, monogamous life style (as defined 
by the contributing physician). None of these 
women, all of whom had their IUDs in place at 
least 20 months (range: 20 months-13 years), 
were symptomatic. In this group of 28 IUDs, 
there were ten which had obvious surface depo-
sits of calcific nature which were grossly iden-
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Fig. 5: A Li ppes 1 oop IUD removed from a patient 
after 4 years of continuous use. The 
IUD is ordinarily clear white. Calcium 
deposits (arrow) have been stained with 
ARS. The IUD is fragmented because 
pieces have been taken for SEM and 
XRMA. Bar= 2cm 
Fig. 6: Scanning electron micrograph of a por-
tion of the string from an IUD. This 
specimen was coated with carbon only. 
There is an obvious coating of the sur-
face of the string; this coating has a 
fibrillar appearance and is fragmented. 
Bar = lOµm 
Fig. 7: Map of Ca localization on the string 
shown in Fig. 6. Note the corres-
pondence of the Ca localization with 
the deposits on the surface of the IUD 
shown in Fig. 6. Bar = lOµm 
In several index cases we carefully examined 
the deposits on both the IUDs and the strings. 
Amongst these cases, two women had multiple 
sexua 1 partners, had worn their Li ppes 1 oop IUDs 
for ten years, had prominent deposits on their 
IUDs and had unusual female reproductive tract 
infections. One patient had actinomycosis and 
aspergillosis and the other had actinomycosis and 
botryomycosis. The organisms were demonstrated 
in CV smears (Gupta bodies), on histologic sec-
tions of endometrial tissues, on IUD surfaces and 
within the crusts on IUD body and tail (Fig. 8). 
The crusts on these IUDs and their tails 
were studied in detail. The crusts were present 
on the surfaces of the IUDs and on the strings at 
about the level of the exocervical as where the 
string exits from the endocervical canal (Fig. 
9). Portions of the strings with attached crusts 
were sectioned histologically after paraffin 
embedment. Parts of the crusted IUDs and their 
strings were examined by SEM and XRMA. 
The paraffin sections of the crusted strings 
demonstrated a complex deposition within which 
microorganisms were easily found. The deposi-
tions consisted of dense, amorphous, PAS positive 
material adjacent to the string or IUD body, a 
layer of calcific material staining red with ARS, 
black with van Kassa and blue with the MoB 
stains, an outer layer of mucoid material and a 
thin surface coat of cells, cell debris and 
birefringent ARS positive crystals (Figs. 10 & 
11). In both instances the deposits stained blue 
with the MoB and black with the van Kassa tech-
niques, indicating phosphate rather than car-
bonate salts of calcium; Ca, P and S peaks were 
also seen on XRMA. 
We commonly find Ca salts in materials 
adherent to IUDs which have been in place longer 
than 2 years, whether or not there is IUD-related 
disease. Conversely, we have not encountered 
prominent IUD surface depositions with or on 
IUDs in place less than 12 months. When 
microorganisms are found they are always asso-
ciated with the IUD or string surface deposits 
(Figs. 12-15). Typically, a mixture of orga-
nisms is seen. The mixture usually includes 
Brown-Brenn positive and negative species; GMS 
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Fig. 8: LM of crust removed from an IUD of a 
patient with actinomycotic infection. 
The Actinomyces organisms are stained 
with silver and appear as long, slender 
black fi 1 aments (arrow). Gomori 
methenamine silver. Bar= 40µm 
Fig. 9: An IUD string with surface deposits, 
embedded in paraffin. Multiple sections 
have been taken from the block. The 
block face reveals the cut surface of 
the surface deposits and the string 
itself. The proteins appear brown 
(arrow head), the string (S) is par-
tially opaque and the Ca deposits 
have a white granular appearance 
(arrow). Bar = 1mm 
Fig. 10: Light micrograph of a section taken from 
the block shown in Fig. 9. The string, 
made of plastic, washed off the 
slide during staining and left a 
central clear space around which the 
surface deposit is found. Proteins in 
the surface deposit stain red (arrow). 
H&E. Bar = 40\Jm 
Fig. 11: LM of a section parallel to that seen 
in Fig. 10. The section has been 
stained identically but is viewed with 
polarized light. The bright band of 
material at the arrow is a remnant of 
the sectioned IUD string. The periphery 
of the material deposited on the string 
is birefringent. The birefringent 
material stains with ARS and is 
apparently a Ca salt. H&E. Bar = 4Q.Jm 
Fig. 12: SEM of the elbow region of a Cu-7 IUD. 
The median ridge (single arrow) is from 
the mold in which the IUD was made. 
There are a variety of deposits upon 
the surface of the IUD. The double 
arrows indicate non-cellular deposits 
characteristic of proteo-calcareous 
material. Large numbers of cells are 
scattered over the surface of the IUD 
(triple arrow). Bar= lOµm 
W.A. Schmidt, K.L. Schmidt 
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Fig. 13: Higher magnification of the IUD seen in 
Fig. 12. Detailed view of the cells 
suggests the presence of RBCs and WBCs. 
Note bacterium at arrow. Bar= 15µm 
Fig. 14: Portion of a Dalkon shield IUD. There 
is an obvious coating on the surface of 
the IUD; this coating is elevated in the 
region of the arrow. The entire surface 
of the IUD is coated. Bar = 20\lm 
Fig. 15: Detail view of the coating of the IUD 
seen in Fig. 12. This IUD came from a 
woman with actinomycotic infection of 
the female reproductive system; she had 
worn the IUD for more than three years. 
The coating is formed of many bacterial 
organisms. Bar = 2).Jm 
bacteria and fungi, are usually intimately 
associated with the crusts (Figs. 8 & 15). We 
have not encountered acid fast stained bacteria 
but believe this relates to technical dif-
ficulties when using this stain with paraffin 
embedded material. The crusts from the two index 
case IUDs with severe PIO provided definite 
Ca and P peaks on XRMA (Figs. 16 & 17). 
Fig. 16: Microanalysis of an IUD from one of the 
two index cases with severe PIO 
following long-term (greater than 3 
years) constant IUD use. There are Ca, 
S, P, and Cl peaks contributed by the 
surface deposits; the Cu and Zn peaks 
represent components of the IUD itself, 
Fig. 17: Microanalysis of the string from 
another patient with PIO. Strong Ca 
and P peaks are present. There were 
obvious deposits upon the surface of 
the string in the region where this 
spectrum was obtained. 
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Discussion 
It is important to exclude the possibility 
of bias introduced by acquisition of only cer-
tain types of IUDs; both collection and popula-
tion biases in our collection are minimized by 
the wide spectrum of medical practices from 
which these IUDs originated and the diversity of 
IUDs obtained. Our studies are based upon a 
collection which contains the same proportion of 
IUD types seen in common usage patterns in the 
US (29). The types of IUDs collected during 
1985 are generally the same as the 1977-1986 
collection, although fewer older style IUDs are 
represented in the later group. Al 1 42 IUDs 
representing the index cases remain in use 
today. 
From the 93 cases we have studied and those 
described in the established literature it is 
possible to recognize common pathologic mecha-
nisms operative in a variety of IUD-related 
diseases and to establish general conclusions. 
It is apparent that early diagnosis of 
IUD-related disease requires morphologic analy-
sis of IUDs, associated tissues or CV smears. 
Specimens submitted for analysis must be accom-
panied by appropriate clinical information. 
Without these clinical data the pathologist is 
bereft of appropriate perspective and must 
necessarily limit the interpretation of the fin-
dings present. The IUD and any associated 
material should be carefully examined and the 
latter must be examined microscopically. In 
most of the cases (65%) we have presented in 
this paper the tissues associated with the IUDs 
were abnormal. In our experience, examination 
of the IUD itself generally lends little 
understanding to the condition of the IUD-bearer 
while examination of the associated tissue does. 
Conjoint examination of both the IUD and the 
host tissues and correlation with clinical 
details is the most productive. From our 
experience we conclude that: 
1. IUDs are altered while in utero. The 
alterations occur as a surface phenomenon which 
affects the IUD, any attached materials, such 
metal coils, and the string. Calcification is 
the most common alteration found. The process 
of Ca salt deposition appears to be time 
dependent; IUDs in place for longer than two 
years commonly have such deposits. 
2. IUD surface depositions are associated 
with a variety of microbial organisms, espe-
cially in those instances where PIO is clini-
cally apparent. The microorganisms are usually 
intimately related to the surface deposit. 
Severe IUD-related inflammatory disease is vir-
tually always associated with prominent IUD sur-
face deposits, but prominent surface deposits 
are not always associated with severe inflam-
mation or disease. 
3. Inflammatory changes in the endometrium 
are common with IUD use. These changes are most 
severe in those instances where the woman is 
symptomatic. The severity of the endometrial 
changes appears synchronous with and directly 
proportional to the extent of IUD surface 
alteration. 
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4. IIJD-rel ated disease tends to affect 
certain kinds of patients. These women often 
have multiple sexual partners and usually have 
worn their IUD for three or more years. 
5. Minor IUD-related disease is usually 
not related to alterations of the IUD itself or 
to histopathologic changes in the endometrium. 
6. Major IUD-related disease is related to 
IUD usage, to the time the IUD has been in situ 
without replacement, to the severity of altera-
tions of the IUD surface and is virtually always 
inflammatory or infectious in nature. 
We have encountered fewer cases of serious 
IUD-related infectious and inflammatory disease 
amongst the 51 cases collected in 1985 compared 
to the 42 index cases which were collected 
earlier because our clinical colleagues now 
regularly remove or change IUDs after two years 
of use. 
Physiologic Effects of IUDs 
Numerous studies have explored the biologic 
effects of IUDs (Table 5). Multiple physiologic 
parameters have been analyzed without identifying 
either the mechanism of action of IUDs or the 
origin of IUD-related disease. The most impor-
tant conclusion from the physiologically 
oriented studies may be found in the second FDA 
report on IUDs (74): 
"It is not yet completely understood how 
any particular IUD prevents pregnancy. It is 
currently believed that the numerous cellular 
and biochemical alterations induced in the endo-
metrium by the presence of the device are 
responsible. The various devices may actually 
have several different mechanisms of action, 
one perhaps being more important with a 
particular device than others. However, in al 1 
species studied, there is one common thread of 
similarity, i.e., the development of a local 
endomet ri a 1 reaction as evi de need by a spec i -
fie type of leukocytic infiltration. This 
reaction seems to interfere in some manner with 
the implantation of the fertilized ovum in the 
uterine cavity and is currently believed 
to represent the primary mode of action of the 
IUD". 
The physiologic studies of IUD bearers have 
documented that a host response occurs to the 
IUD and that this response may be IUD-specific. 
Characteristics of the host response have been 
clarified by morphologic and microanalytic stu-
dies. These studies reveal greater detail about 
the nature of the host/IUD interaction and the 
changes which occur to the host and IUD. They 
also shed considerable light upon the mechanisms 
involved in IUD-related disease. Such studies 
have involved cytologic, histologic, TEM, SEM 
and microanalytic methods. 
Host Response to IUDs 
Initial cytologic studies performed during 
the 1970s detected IUD-induced host responses 
which affected both the host tissues and the 
IUD. Sagiroglu and Sagiroglu showed that smears 
of IUDs removed after being in place from five 
hours to 39 months had a surface accumulation of 
host cells but that bacteria were associated 
with the IUD only transiently for the first five 
days ( 59). In 1971, Highman reported on the 
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TABLE 5 
BIOLOGIC EFFECT OF IUDS 
Physiologic Studies 







Serum progesterone 1-2 days late; earlier onset of menses (25). 
Endometrial estradiol-17- B -dehydrogenase unaffected (69). 
4. 1980 Cu-SC 
No changes in serum copper or urinary copper excretion (54). 







Decreased serum iron and transferrin saturation; hemaglobin constant (15). 
Ovarian function unaffected; ovarian-endometrial asynchrony (12). 
8. cu+2ion 
No changes in coagulation factors (41). 
1981 
9. 1981 * ns 
Caused dose dependent increase in myometrial contractility (43). 
Lower uterine fluid fibrinolytic activity. 
10. 
Increased serum proteinase inhibitors in uterine fiuid. 
Increased urokinase in uterine fluid (4,6,7,41). 







Elevated endometrial tissue PGF but not PGE (74). 
Severe infection or increased tubal transport rate. 
Inflammatory response (74). 
Increased lysosomal hydrolases, protein, non-protein nitrogen and urea. 
Increased AlPase, AcPase, glycogenesis, phospholipids, oxygen consumption, total 
proteins, RNA/DNA ratio (74). 
Asynchronous endometrial development. 
Elevated serum C-reactive protein (74). 
ns: IUD type not specified 
association of calcific bodies with IUD use 
(27). In that same year, Gupta et al. discussed 
the changes which occur on the surface of the 
IUD and suggested that the host is capable of 
degrading the IUD (23). The studies of Fornari 
demonstrated that IUD use unequivocally results 
in tissue changes, which affect both the endo-
metrium and the endocervix, appear in diagnostic 
CV smears ( 13). They showed these changes, 
which may mimic neoplastic alterations, were 
inflammatory in origin. 
By 1979 it was apparent that IUDs were 
associated with a pronounced host response and 
that deposits occurred on the surface of IUDs. 
Trebichavsky and Nyklicek showed in a TEM study 
directed at the cellular response of the host to 
the IUD that the entire IUD was covered by host 
cells by 48 hours after insertion (68). Over 
time the cellular covering changed from PMNs 
to macrophages. Eventually the IUD became 
covered by a variety of cellular types and 
debris and 47% of IUDs worn for three or more 
years had bacteria on their surface even though 
35% of these were sterile by culture methods. 
In 1981 two important papers defined the 
nature of the host cellular response to sup-
posedly biologically inert IUDs. Casslen et al. 
compared the cellular composition of uterine 
fluids from 75 otherwise healthy Cu-T200 IUD 
users with similar fiuid obtained from 48 non-
users and found significant differences (5). 
The IUD-user uterine fluids demonstrated little 
or no change in the number or nature of endo-
metrial eel ls and showed a modest increase in 
the numbers of mast cells and eosinophils. 
Marked changes were seen in the numbers of 
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lymphocytes, phagocytes and granulocytes of the 
uterine fluids of IUD users. There was a 
thirty-fold increase in the number of lymphocy-
tes and phagocytes, the latter of which also 
accounted for roughly one-third of the total 
cells in the fluid. PMNs accounted for almost 
two-thirds of the cells in the uterine fluid and 
showed a 300 fold increase in number. 
A similar study by Kobayashi et al. in 
Japan confirmed the host cellular inflammatory 
response to the IUD (39). They studied 26 
healthy women who had used the Ota ring for one 
to five years duration and quantified the cells 
obtained from the IUDs at removal • They found 
an IUD cellular 'coating' composed of 49% 
macrophages, 42.7% PMNs, 4% endometrial cells, 
1.3% mast cells and 3% assorted other cells. On 
the average there were 65.5x10(4) cells/IUD; the 
range was 1.3-280x10(4) cells/IUD. They also 
identified inhomogeneity in the host response to 
the IUD and divided their patients into two 
groups based on more or less than 5x10(5) 
eel ls/IUD. In the former category there were 10 
women with an average of 144.3+79.2x10(4) 
cells/IUD while in the latter group 16 women had 
an average of 18.3+3.3x10(4) cells/IUD. This 
variation in host response documented at the 
cellular level previously has been seen histolo-
gical ly. In the histopathologic studies, 
however, the variability of the host response 
seems to be related to the type of IUD used and 
its duration of use. The first histologic study 
by Willson et al. in 1965 examined endometrial 
changes in 292 women wearing polyethylene 
Margulies spiral IUDs (72). They found the 
endometrium responded to the ovarian cycle 
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(although there seemed to be some delay in the 
endometrial response), congestion of the super-
ficial vascular sinuses of the endometrium and 
increased edema forrr,.:t ion. They al so 
demonstrated a 19% incidence of chronic endo-
metritis in those women who had worn their IUD 
for 4 - 25 months. 
The role of inflammation in IUD-associated 
histologic changes of the endometrium has been 
confirmed upon multiple occasions. In 1968, 
Ober et al. reported on 200 endometrial biopsies 
from women who had worn various kinds of IUDs 
(52). This group of patients included 107 symp-
tomatic and 93 asymptomatic women. In the endo-
metrial biopsies from these women they 
identified the following as minor lesions: 
lymphocytosis, granulation tissue, focal gland 
loss and asynchrony. Among major lesions they 
included acute and chronic endometritis. The 
biopsies from the 107 symptomatic women revealed 
25.2% of women with major lesions and 45.8% of 
women with minor lesions. Amongst the asymp-
tomatic women only 9.7% had major lesions seen 
in their endomet rial biopsies while 50. 5% had 
minor lesions. 
With some notable exceptions to be 
discussed below, the endometrial inflammatory 
response associated with IUD use does not 
necessarily seem to be IUD specific. Moyer and 
Mishel l studied the endometrial response to 
Lippes loop IUDs which had been placed preopera-
tively in 167 women scheduled for hysterectomy 
( 46). The specimens were exa1ni ned at various 
times after insertion, the range being a few 
hours to as long as five years. All specimens 
demonstrated inflammatory responses composed of 
PMNs, plasma cells, and mononuclears; the mono-
nuclear infiltrates persisted for years. An 
elevation of endometrial cavity fluid protein 
content was also characteristic of women wearing 
I I/Os. 
The nature and intensity of the pervasive 
endometrial inflammatory response, particularly 
in the case of polyethylene IUDs, seem to be 
related to the time the IUO had been in situ. 
Moyer et al. studied 75 patients who had Lippes 
loop IUDs placed prior to hysterectomy (47). 
They found a transient, post-insertion con-
tamination of the endometrial cavity with low 
virulence bacteria, a contamination which was 
spontaneously resolved in all cases within 48 
hours after insertion. Those endometria which 
contained the IUDs for up to six days before 
hysterectomy demonstrated a stromal inflammatory 
infiltrate composed of PMNs, lymphocytes and 
monocytes. When the IUDs had been in place for 
7-49 days the inflammatory infiltrate was com-
posed of neutrophils, plasma cells and 
increasing numbers of monocytes and there were 
also focal ulcerations of the endometrial sur-
face. The inflammatory infiltrates persisted in 
those women who wore their IUOs for several 
months before hysterectomy. Similarly, Hayashi 
et al. found in 145 women who had used a variety 
of IUDs, that the extent of endometrial inflam-
mation was greater in those who had worn their 
IUDs for more than two years (26). 
Ober et al. studied in greater detail the 
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temporal relationship of inflammation and symp-
tomatology in 393 women who used a Lippes loop 
IUD for 18 months or longer ( 51). Among the 60% 
who remained asymptomatic for 3 or more years 
there was a 2.5% incidence of endometritis. The 
20% of women who became symptomatic during 
the first 3 years had a 20% incidence of endo-
metritis and the 20% of women who became symp-
tomatic after more than 3 years of continuous 
IUD use had a 40% incidence of endometritis. In 
all the women the symptomatology was meno-
metrorrhagia and pelvic pain. 
In some instances, the type of IUD does, 
however, influence the host response. Mestranol 
loaded spring coil silastic IUDs, for instance, 
are associated initially with endometrial 
hyperplasia and later with endometrial atrophy 
(11). Whether simultaneous drug delivery ame-
liorates the inflammatory response is not clear 
in this study because the IUDs were worn no 
longer than 12 weeks. Similar problems plague 
interpretation of tissue responses to pro-
gesterone loaded IUDs which are designed to be 
used for no longer than 12-24 months. The addi-
tion of elemental copper to the IUD does 
increase the inflammatory response (10,53) and 
it has been shown that intrauterine metallic 
copper results in PMN infiltrates in the endo-
metria of animals (10). 
It is now apparent that polyethylene, 
polyethylene plus metal and metallic IUDs all 
are associated with endometritis (49). In fact, 
the inflammatory process involves the Fallopian 
tubes as well. In 1984, Coll ins et al. (8) 
demonstrated, in a population of 73 women (20 
IUD users, 25 OCP users and 28 barrier method 
users) an excess of Fallopian tubal inflammatory 
changes in those who used IUDs. Others (49) 
have also shown that IUD use is associated with 
both endometritis and salpingitis. 
A characteristic example of IUD-type speci-
fic endometrial inflammatory response is pro-
vided by the Majzlin spring IUD. Ober et al. 
studied 69 endometrial biopsies from women with 
this stainless steel IUD (50). These biopsies 
came from 68 patients, 12 of whom were asymp-
tomatic. The asymptomatic patients had worn 
their IUDs for 2 to 10 months and significant 
inflammatory changes were seen in 16.6% of their 
endometrial biopsies. Amongst the 56 symp-
tomatic women, who had worn their IUD for 0.5 to 
15 months, 78.6% of the biopsies had significant 
inflammatory changes. In 36.3% of all the biop-
sies there were bacteria demonstrated by 
Brown-Brenn staining of paraffin sections. In 
the case of the Majzlin spring IUD, which was 
composed of iron, chromium, nickle, and to a 
lesser degree manganese, silicon, sulfur, carbon 
and phosphorus, the endometritis seems to have 
been metal lo-chemical in origin. Chromium and 
nickle are particularly suspect as primary irri-
tants; the bacteria were not thought to be the 
primary cause of the inflammatory process. 
Electron microscopic studies have revealed 
exciting details about the relationship between 
the host and the IUD. The IUD itself, 
regardless of type, produces fundamental changes 
in the cellular architecture of the reproductive 
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tract epithelium irrespective of the inflam-
matory process. In 1984, Wollen et al. found a 
change in Fallopian tube epithelial cell popula-
tions of 12 healthy, non-pregnant women using a 
variety of IUDs (73). They demonstrated a 
decrease of ciliated endosalpingeal cells from 
40'.~ to 20%. 
Other studies have examined in greater 
detail the ultrastructural changes associated 
with IUD use. In 1976, Hsu et al. studied endo-
metrial tissues obtained from 7 patients who 
ranged from 39-51 years of age and who had Cu-T 
or Cu-7 IUDs placed from 2 to 54 days prior to 
hysterectomy ( 28). By LM they found an i nfl am-
matory response which was present in the lumen, 
glands and stroma and which was greatest at the 
11!0 sites. By TEM, there were superficial endo-
metrial erosions at the IUD contact site, intra-
epithelial lymphocytes and neutrophils, giant 
lysosomes evidencing cellular damage short of 
cell death, loss of cilia and an absence of the 
nucleolar channel system where such a channel 
system should be found. On SEM examination they 
found endometrial surface epithelial cell micro-
villar changes, a prominent mucoid inflammatory 
response, erosions of the surface epithelium and 
RBCs and WBCs scattered over the endometrial 
surface. Using energy dispersive microanalysis 
they were unable to detect copper in the speci-
mens, their limit of resolution being 
5x10(-18)g/200µm diameter. The absence of 
detectable Cu in the tissues is curious since 
the element is clearly a stimulant of the endo-
metrial inflammatory process (10,53). Absence 
of Cu also was shown by Gonzalez-Angulo and 
Aznar-Ramos who studied endometrial tissues from 
12 women who wore Cu-T200 IUDs for 6-12 months 
(18). In their study they were unable to 
demonstrate tissue Cu using the rubeanic acid 
histochemical technique and energy dispersive 
XRMA. They also demonstrated evidence of cellu-
lar injury on TEM by noting mitochondrial matrix 
vacuolization, myelin figures and increased num-
bers of lysosomes. 
Sheppard and Bonnar concentrated upon 
microvascular changes in IUD exposed endometria 
as demon st rated by TEM studies ( 63). They 
studied endometria from 15 patients who had worn 
a variety of IUDs for various periods of time 
ranging from 4 to 48 months. The majority of 
tissue changes were associated with the actual 
sites of IUD contact although similar but lesser 
changes were seen in adjacent endometrium. The 
alterations were associated directly with the Cu 
content of the IUD, the proximity of the IUD to 
the endometrium and the area of the IUD/endo-
metrial interface. The pathologic features 
observed included microthrombi, platelet/fibrin 
aggregates in endothelial gaps of the super-
ficial stromal capillaries under the IUDs, an 
associated stromal hemorrhage and superficial 
erosi ans of the endometri al surface. 
IUD/String Alterations 
IUD-associated histologic responses are 
accompanied by changes which involve the IUD 
itself. These IUD alterations may be 
categorized under the concept of IUD 
biotransformation. IUD biotransformation is a 
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biphasic process comprised of: 1. biodegrada-
tion of the IUD and/or the string, and 2. 
biodeposition on the IUD and/or the string (61). 
Table 6 summarizes major contributions to the 
concept of IUD biotransformation. 
The first observations of IUD biotransfor-
mation were published by Gupta et al. (23) who 
demonstrated encrustation and disintegration of 
Lippes loop IUDs using incident LM. Johnson et 
al. studied IUD encrustation in greater detail 
using incident LM and x-ray diffraction quan-
titative analysis (30). They demonstrated 
calcium salt deposition on various kinds of 
IUDs, considered calcium carbonate to be the 
major component of such calcification and 
suggested that Ca deposition tended to increase 
with the duration the IUD was used. Biale et 
al. (3), using SEM, chemical and stress analysis 
of Lippes loop IUDs, found calcium carbonate 
upon and corrosion of the surface and increased 
rigidity the longer the IUD was in place. 
Rosenfeld et al. (58), using SEM and XRMA, 
demonstrated similar Ca salt deposition on the 
Cu wire of Cu-7 IUDs. Keith et al. (34), also 
using SF.Mand XRMA, performed a detailed study 
of IUD crystalline surface deposits on various 
I IJ[)s. They revealed apatite as the major 
crystal of the calcification and specifically 
identified an euhedral crystal rosette composed 
of [Ca5(P03l3(F,Cl ,OH)]. 
Disintegration of the IUD, its string or 
both has been repeatedly observed; this is the 
process which we prefer to name biodegradation. 
Changes in metallic components of IUDs, par-
ticularly Cu wires, are not altogether 
surprising since the metal is placed in an 
electrolyte solution for prolonged periods of 
time. Larsson et al. studied wire weights of 
coiled Cu wire IUDs and demonstrated a decrease 
in wire weight over time (42). The change was 
minimal and did not appear to affect contracep-
tive efficacy. Kosonen and Thiery, using LM, 
similarly demonstrated wire corrosion and frac-
ture of IUDs with coiled Cu wire (40). Similar 
results have been obtained in animal studies 
using wires made from a variety of metals. 
Using XRMA and metallographic techniques Gonen 
et al. (17) demonstrated fragmentation of and 
deposition on the surface of wires composed of 
pure Au, Pt, Cu and alloys of these three 
metals. The deposits on the outer surface of 
these wires revealed elemental Ca, Cl, and S by 
XRMA. 
Destruction of the plastic JU[) or its 
string seems at first glance unlikely. In fact, 
IUDs were reintroduced early in the 1960s 
because plastics were available and because they 
appeared to be biologically inert; it was 
suggested that the body essentially ignored the 
IUDs made of polyethylene. The host reaction to 
the IUD involves not only a cellular response 
but includes the capacity to degrade synthetic 
materials previously thought impervious to 
biologic action. Biologic degradation of both 
nylon materials and Vi cryl and Dex on sutures, 
the latter two being composed of copolymeric 
glycolide and lactide and copolymeric glycolic 





Year Study Type 
1971 Incident LM 
1975 Incident LM, TEM, 
bacteriologic 
1975 Incident LM, TEM, 
bacteriologic 




Encrustation (Lippes loop). 
Disintegration of and bacterial colonization within string 
(Dalkon shield). 
Wicking effect of structurally unique tail (Dalkon shield). 














X-ray diffraction, carbonate, the major crystalline component, tends to increase 
quant. analysis w/ duration~ situ. 
SEM Surface alterations and depositions (Dalkon shield). 
SEM, Calcium carbonate deposition, surface corrosion, increased 
chemical analysis, rigidity {Lippes loop). 
stress analysis 
1980 SEM, TEM, 
XRMA 
Bio-material: cells, fibrin. 



















Tendency to increasing calcium deposits with time (Lippes loop, 
Saf-T-Coil, Dalkon shield, Cu-7, Progestasert™). 
Au, Pt, Cu and duplex wires; rats. 
Ca, Cu, Cl , S formed deposits with inner and outer layers; 
fragmentation. 
Ca deposits on Cu wire (Cu-7). 
Minimal decrease in wire weight over time; not related to 
contraceptive effectiveness {Cu devices). 
Corrosion and breaking of wires {Cu devices). 
Bacteria on and in Dalkon shield tail; tail provides niche 
and acts as wick. 
Deterioration of Dalkon shield tail. 
Detailed study of crystalline surface deposits; various IUDs; 
apatite, euhedral crystal rosette seen [Ca5{P04)3 {F ,Cl ,OH)] 
on 15 year in situ Lippes loop. 
Cellular and acellular crust on various IUDs; Ca salts 
present {phosphates?); crust/fibrillar-amorphous layer/IUD 
interface seen suggests sequential crust formation. 
*see text references for detailed citations 
previously {16,56,64). 
The Dalkon shield IUD is a classic example 
of biotransformation resulting in IUD-related 
disease. Gaudoin et al. used SEM to show that 
the Dalkon shield was altered in situ and that 
both surface depositions and alterations were 
produced (14). Roberts et al. {57) revealed, 
with SEM, that the Dalkon shield IUD tail 
have demonstrated bacteria on and in the 
Dalkon shield tail. Tatum et al. {66,67), using 
incident LM, TEM and bacteriologic studies, 
demonstrated disintegration of the Dalkon shield 
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IUD and bacterial colonization of the string. 
Tatum et al. also demonstrated that the 
structural design of the Dal kon shield IUD tail 
permitted a "wicking effect" whereby bacteria 
continually gained access to the endometrial 
cavity {67). The Dalkon shield IUD tail has a 
polyfilamentous nylon core surrounded by a nylon 
sheath. During manufacture the nylon sheath was 
damaged at points where knots were tied and at 
these sites biologic degradation of the nylon 
was greatest. The knots 1~ere tied at the distal 
end of the tail and al so at the point where the 
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tail attached to the IUD, the latter knot being 
within the cavum uteri when the IUD was in 
place. Using correlated in vivo and in vitro 
studies, Tatum et al. ( 67) demon st rated that 
motile bacteria, pathogens included, could gain 
access to the inner core of the string. The 
organisms enter either through the open end in 
the vagina or via mechanically induced or hydro-
lyzed breaks in the distal knot, travel up the 
string and gain access via the proximal knot 
site where the string is attached to the tail. 
In the case of the Dalkon shield a combination 
of poor architectural design and inadvertent 
poor choice in materials conspired to place the 
users of these IUDs at high risk for inflam-
matory and infectious disease. 
The material deposited upon the surface of 
the IUD, the biodeposit, is not composed solely 
of inorganic Ca salts. Using SEM, TEM and 
XRMA, Sheppard and Bonnar studied deposits on 
the surface of a variety of IUDs (Lippes loop, 
Saf-T-Coil, Dalkon shield, Cu-7 and 
Progestasert™) and found Ca bearing materials 
which tended to increase in amount with the time 
the IUD was in situ ( 63). They al so found cells 
and fibrin deposits as integral parts of the 
biodeposit material. In the most recent study, 
Khan and Wilkinson, using SEM, TEM, XRMA and x-
ray diffraction, studied the surface deposits on 
a variety of IUDs {36,37). Their data indicated 
that most of the Ca salts present were car-
bonates in the form of ca 1 cite. These Ca salts 
seemed to be intimately intermixed and asso-
ciated with cellular and non-cellular materials 
to produce a complex crust. Their studies 
revealed the structural organization of the 
biodeposit: the layer closest to the IUD was 
fibrillar and rather amorphous and the outer 
crust contained crystalline materials. These 
results suggested a definite sequence in crust 
formation, findings entirely consonant with the 
frequent observation that the formation of IUD 
biodeposit is time dependent. 
IUD Related Disease 
These well documented changes which involve 
the IUD, the host and the host-IUD interface may 
be operative in the genesis of IUD-related 
disease and demand interpretation in that con-
text. To do so it is important to place 
IUD-related disease in perspective. The studies 
cited above demonstrate that changes of the IUD 
and of the host tissues are both time related, 
as is the generation of IUD-related disease. 
Prolonged duration of the IUD in utero is not, 
however, synonomous with IUD-related disease. 
Kaye et al. have shown in their patient popula-
tion that long term use of IUDs is not asso-
ciated with increased morbidity or mortality 
{33). They studied 200 women who used a variety 
of IUDs {Lippes loops-A, -C and -D; Dalkon 
shield; Saf-T-Coil; Cu-T200). In this popula-
tion there were 670 insertions of IUDs and 
they experienced as complications up to 8% 
pregnancies and 3.2% infections, none of the 
latter being serious. These women had worn 
IUDs continuously for at least 10 years; during 
this time period there had been numerous 
reinsertions of 'fresh' IUDs. 
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Nonetheless, IUD use is associated with 
disease. Kahn and Tyler, in a six month study 
of 7900 IUD-related hospitalizations during 
1973, derived an estimated morbidity rate of 
3-10 hospitalizations/1,000 woman-years of IUD 
use and an estimated death rate of 1.0-7.3 
deaths/1,000,000 women-years of IUD use (31,32). 
Thus, there seems to be a category of patients, 
perhaps different from the private practice, 
well motivated, middle class women in the study 
of Kaye et al. {33), who are at risk for serious 
disease and even death as a result of IUD use. 
The relationship between socioeconomic status, 
sexual practices and IUD-related disease are 
thoroughly discussed elsewhere {35,66). 
Some insight may be obtained by examining 
the type of IUD-related disease and relationship 
of those diseases to the type of IUD used as 
shown in Tables 7 and 8 respectively. From 
Table 7 it is apparent that minor IUD-related 
disease is rare to uncommon and is associated 
with physiologic alterations. These physiologic 
alterations usually occur so soon after IUD 
insertion that the processes of biotransfor-
mation do not seem likely causes of the minor 
IUD-related diseases. The major IUD-related 
diseases, on the other hand, are temporally con-
cordant with the appearance of host tissue 
changes and IUD biotransformation processes. 
Amongst the variety of mechanisms known or 
thought to be at the root of serious IUD-related 
disease, inflammation and infection are those 
which occur most commonly. Similarly, when 
IUD-related disease is classified according to 
type of IUD used {Table 8), it is apparent that 
infectious/inflammatory disease is the most com-
mon type of disease process and is also most 
commonly associated with the more serious 
complications of IUD-related disease, reproduc-
tive failure and death. 
We propose that serious IUD related disease 
is caused by or is a direct consequence of 
biotransformation processes and that most of the 
induced diseases are mediated by inflammation 
and infection operating either separately or in 
tandem {61). We propose that inflammation/ 
infection is the paradigm of serious IUD-related 
disease, the interaction of these processes 
being demonstrated in Fig. 18. As proof of the 
central role of biotransformation processes in 
the initiation of IUD-related disease we invoke 
the multitude of morphologic and microanalytic 
studies cited above; among these reports the 
results by Khan et al. are typical. 
The observation by Khan and Wilkinson {36) 
that there is an amorphous layer immediately 
adjacent to the IUD upon which the protea-
calcareous deposit forms is important and 
suggests that the first step in IUD biodeposi-
tion is the formation of a proteinaceous surface 
coating similar to the salivary pellicle which 
precedes dental plaque formation (48). Because 
IUDs, except for those which are medicated, do 
not interfere with the menstrual process the IUD 
is exposed during menses to a wide variety of 
proteins ordinarily confined to the stroma by 
the endometrial epithelium. These proteins may 
add to the surface coating of the IUD. Amongst 
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Fig. 18: Cartoon characterization of the proposed paradigm for serious IUD-related disease. The 
presence of the IUD induces changes in the host tissues and a host reaction which alters 
the IUD. These alterations of the IUD result in accentuation of the host responses. Changes 
in the host tissues acting in concert with the altered host/IUD milieu result in the 
inflammatory and infectious diseases which constitute the majority of serious IUD-related 
disease. 
these stromal proteins are the ubiquitous extra-
cellular matrix proteins, laminin, fibronectin 
and collagen IV. 
It is important to note that fibronectin 
binds non-covalently to gram-positive and gram-
negative bacteria and yeasts and that laminin 
receptors have been identified on invasive 
strains of S. aureus {44, 70). Vercellotti et 
al. have shownthaf some gram-positive bacteria 
bind to and may be aggregated by fibronectin, 
laminin and collagen IV; in this study the 
authors concluded that, "These adhesion molecu-
les play a role in the normal colonization of 
sites by microorganisms and in invasion during 
pathogenesis" (71). Others have shown that all 
the epithelia of the reproductive tract, in-
cluding the endometrium, have a prominent glyco-
calyx. In the vagina it is thought that, "The 
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adherence of many types of bacteria to the vagi-
nal epithelial eel ls appears to be effected by 
the interaction of polyanionic components on the 
surface of both the bacterial and epithelial 
cells" {38). Such adhesion mechanisms apparent-
ly play a role in Fallopian tube infections (9) 
and may be similarly operative in the coloniza-
tion of biotransformed IUDs by pathogens. 
Further supporting evidence for these adhe-
sion mechanisms may be found in SEM studies of 
osteomyelitis in which infecting bacteria grow 
on the dead bone, essentially a foreign body, in 
coherent microcolonies found within an adherent 
biofilm (19). The biofilm of osteomyelitis has 
a fibrous matrix and contains host cells and 
bacteria surrounded by matrix. The bacteria are 
further enveloped by an exopolysaccharide 
polymer, which stains with ruthenium red. The 
W.A. Schmidt, K.L. Schmidt 
TABLE 7 
CLASSIFICATION OF IUD-RELATED DISEASES AND COMPLICATIONS 
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I.Chronic Up to 47% 
salpingitis 
2.Infertility Increased 
3. Ectopic pregnancy 115%" 
4.Septic abortion ? 
5.PID 1.3-8% 






1. 0-7. 3/ 
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2 yea rs 
Mechanism(sl 
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Faulty insertion, design failure, etc. 
Poor size match 









Puerperal perforation and migration 
Anticoagulant associated hemorrhage 
Usually infection 
a= increase over spontaneous incidence in absence of IUD. 
TABLE 9 
RECOMMENDATIONS REGARDING PATIENT CARE 
1. Change IUDs regularly, perhaps every two 
years, and interrupt the biotransformation 
process. 
2. Carefully counsel patients about compl ica-
tions, not only what can happen but also 
which alterations in normal patterns are 
warning signs. 
3. tvaluate and observe with great care those 
women who are symptomatic no matter how 
protean their symptoms. Consider removing 
the IUD and using an alternative means of 
contraception. 
4. Examine carefully the removed IUD and 
adherent material, no matter how small the 
fragments may be. 
5. Follow carefully those women using IUDs. 
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authors of the osteomyelitis studies conclude 
that, "The adherent mode of growth may reduce 
the susceptibility of these organisms to host 
clearance mechanisms and antibiotic therapy and 
thus may be a fundamental factor in acute and 
chronic osteomyelitis". Such mechanisms of 
escape from host defenses may permit growth of 
pathogens within IUD biodeposits and the attain-
ment of sufficient numbers to establish an 
infectious disease process. 
The model which we propose for IUD-related 
diseases is shown in Figure 19. The model is 
concordant with our present understanding of the 
types of disease processes associated with IUDs, 
the types of IUDs associated with disease and 
with the multitude of structural and microanaly-
tic studies of IUDs. The construction of the 
model has been entirely dependent upon data from 
morphologic and microanalytic studies. Our 
understanding of IUD-induced alterations in host 
tissues, the alterations on and of the IUD and 
the apparent interactions between these forces 
to produce IUD-related disease, in fact, have 
come as a result of morphologic analysis, 
thorough microanalytic probing and careful 
correlation of clinical and pathological obser-
vations. 
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TABLE 8 
CLASSIFICATION OF IUD-RELATED DISEASE BY IUD TYPE 
TYPE 
1. Diamond +Au 
2. Silkworm gut 
3. Silkworm gut and Ag 
4. Nylon 
5. Stainless steel 
6. Plastics: 
Saf-T-Coil 
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Minor diseases, Hormonally related + 
Major diseases, 
Ectopic pregnancy Unknown + 
lQ_jJ ague 
PROGNOSIS 

























IUDs returned to use at a time permissive 
to the introduction of new devices, permissive 
to a fault, in fact. It is difficult to con-
ceive how such devices could be introduced today 
without studies more thorough than were per-
formed in the 1960s, recognizing that at that 
time bioengineering and materials science were 
fledgling areas. Today the truly inert IUD 
remains as elusive as ever and although 
IUD-related disease persists the IUD continues 
to be used by mi 71 ions of women. Even though 
two maJor manufacturers of IUDs have withdrawn 
from the market there remain others and the IUD, 
as noted above, remains a popular contraceptive 
device. Those IUDs still in use are not exempt 
from the types of changes or proposed mechanisms 
of disease listed above. It is important, 
therefore, that patient care and observation be 
modulated by our current understanding. Table 9 
lists recommendations regarding care of patients 
with IUDs. 
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It also seems unwise to ignore the efficacy 
and popularity of IUDs as a contraceptive device. 
Rather, we should capitalize upon our experience 
to date, continue to carefully observe those IUDs 
which remain in use and design IUDs which are 
both safer and effective. When possible future 
trends in IUD design and evaluation are con-
sidered (Table 10) it is apparent that morpho-
logic and microanalytic studies must be continued 
by multidisciplinary teams. 
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Fig. 19: netails of the biotransformation processes which contribute to the genesis and progress of 
serious IUD-related disease. a. a cartoon view of the IUD surface, seen on cross section. 
The protea-calcareous deposition is formed from both cellular and humoral components. Under 
this layer there are changes which affect the physical structure of the IUD; these changes may 
















The outer layer of the biodeposit represents the "recent event layer" within which may be 
found RBCs, WBCs, protein strands, crystalline material and bacteria of various kinds. 
b. the variables which contribute to the two major components of the biodeposit are shown. 
The major variables seem to be proteins of various kinds, the nature of the materials of which 
the IUD is made, Ca salts, biodegradation processes and time in situ. 
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Polymorphonuclear neutrophils 
Platinum 
Red blood eel ls 
Sulfur 
Scanning electron microscopy 
Transmission electron microscopy 
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White blood cells 
x-ray microanalysis 
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Review of IUD-related Disease 
TABLE 10 
FUTURE TRENDS IN IUD DESIGN AND EVALUATION 
1. Continue to explore the application of new 
materials, such as polyether urethane. 
2. Continue to explore the role of metals in 
terms of their capacity to promote contra-
ception, inflammation and bacteriostasis. 
3. Continue to explore the role of the IUD as a 
means of delivering pharmacologic agents 
which may influence contraception, the host 
response, biotransformation and control of 
micro-organisms. 
4. Continue to explore the nature of biotrans-
formation, its consequences, the molecules 
which participate in the phenomenon and the 
control mechanisms involved. 
5. Design and fund these studies to allow long-
term follow-up of no less than 5 years, 
utilizing multidisciplinary teams of 
materials scientists, reproductive biolo-
gists, obstetrician/gynecologists and repro-
ductive pathologists. 
6. Include in such studies a wide range of 
patients of diverse races, socioeconomic 
levels, sexual behaviors and marital and 
reproductive status. 
7. Use the full range of clinical studies and 
basic science examinations which have proven 
so useful in providing our current fund of 
knowledge of IUD-related disease. 
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Discussion with Reviewers 
S. R. Khan: Knowing what we know now, would you 
recommend use of the IUD as a contraceptive 
device? 
Authors: This is a difficult question; its 
answer must be addressed at two levels. The 
literature which we have reviewed and multiple 
other articles which we have not cited attest to 
the usefulness of the IUD as a means of contra-
ception. In addition, this collective 
experience clearly identifies the conditions 
under which IUD use is likely to be safe and 
those conditions in which serious disease may be 
encountered as a direct result of using an IUD. 
Unfortunately, there is no guarantee that signi-
ficant IUD-related morbidity will not be encoun-
tered under the best circumstances. The 
inability to predict which women are at risk for 
serious IUD-related disease leads to threatening 
medico-legal liability. In the US, the 
IUD-related litigation risk is well understood 
by medical and legal professionals and the women 
who use IUDs. Georgia Dul lea's article in the 
New York Times (Liability Crisis Complicates 
Cont race pt ion; Style, B8, Monday, May 19, 1986) 
is perhaps a fitting puhlic summary; she quotes 
therein the comments of one gynecologists: "No 
sane physician would dare give an IUD today, 
except to his wife". 
Reviewer V: Why were the IUDs collected in 1985 
sent to you? 
Authors: It is t~e practice in our institution 
tosena all IUDs which are removed to the patho-
logy laboratory for examination. This allows 
the attending physician to explore the possibi-
lity of clinically silent but serious 
IUD-related disease when the results of the 
pathologist's examination suggests such a possi-
bility. Examples of suggestive findings inclu-
de: Gupta bodies on CV smears obtained 
coincident with IIJD removal, purulent and malo-
dorous deposits on the IUD and string, and 
significant histopathological alterations in 
tissues attached to the IUD and string. 
Reviewer V: What is a major IUD-related disease 
and what is a minor one? 
Authors: In the course of our extensive l itera-
ture -revie1~ we perceived the need to distinguish 
amongst the wide variety of IUD-related compli-
cations. As noted by Reviewer V, "IUD asso-
ciated complications occur most frequently 
during the first 12 weeks of insertion---." 
These complications are, for the most part, 
minor occurrences and transient situations which 
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had to be distinguished from long-term or life 
threatening morbidity subsequent to IUD use. It 
is our perception that the mechanisms operative 
in the former are distinctly different than 
those functioning in the latter. Our defini-
tions of these two broad categories of 
IUD-associated complications are: 
MINOR IUD-RELATED DISEASE 
conditions which do not -
threaten or destroy reproductive 
capacity 
seriously impair or permanently 
destroy work capacity 
require more than ambulatory care 
most are physiologic reactions or 
limited excesses or normal physiologic 
functions (ie, cramping and expulsion 
of the IUD) 
are usually treated easily, inexpen-
sively and do not need extensive follow-up 
MAJOR IUD-RELATED DISEASES 
conditions which -
are life threatening or fatal 
threaten, impair significantly or 
destroy reproductive capacity 
seriously impair or permanently destroy 
work capacity 
require in-patient care and extensive 
follow-up 
often require surgical intervention 
Reviewer V: Why don't you get oral abscesses 
and infections with prolonged dental fillings? 
Should IUDs be made of similar materials? 
Authors: There is an instance in which intra-
oral-dental 'crust' formation is associated with 
a disease process similar to serious infections 
related to IUD use. The formation of dental 
plaque, particularly where that plaque extends 
into the gi ngi vo-dental sul cus, is related to 
periodontal disease and tissue destruction. 
In both settings it appears that the crust and 
micro-organisms play a synergistic role. There 
is much merit to the suggestion that exploration 
of a wider range of materials might produce a 
safer IUD. 
